🇺🇸 FDA
Patent

US 12409206

Use of cyclosporine analogues for treating fibrosis

granted A61KA61K38/13A61K45/06

Quick answer

US patent 12409206 (Use of cyclosporine analogues for treating fibrosis) held by Hepion Pharmaceuticals, Inc. expires Mon Sep 04 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Hepion Pharmaceuticals, Inc.
Grant date
Tue Sep 09 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 04 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K38/13, A61K45/06, A61P, A61P1/16